In conclusion, our data have demonstrated that hepatic WTAP is a key integrative regulator of ectopic lipid accumulation and inflammation during NASH progression with an involvement of IGFBP1, CD36 and cytochemokines such as CCL2. Here, CCL2 is linked to metabolic dysfunction-associated steatohepatitis.